Table 2 Summary of literature on chronic inflammatory demyelinating polyneuropathy (CIDP) in psoriasis patients
Case | Gender | Age (years) | Previous biological treatment | Treatment | The curative effect |
|---|---|---|---|---|---|
1 [6] | male | 58 | - | One IVIG treatment (400 mg/kg/d for 5 days) | Sensory impairment was significantly improved |
2 [7] | male | 49 | Infliximab (5 mg/kg at weeks 0, 2, and 6, followed by an 8-week interval) was treated for 8 months | Monthly IVIG treatment (400 mg/kg/d, for 5 days) | Limb weakness was significantly improved, and clinical stability was achieved |
3 [8] | male | 42 | Adamuzumab (80 mg twice weekly) was treated for 1 year | IVIG treatment (details not available) | CIDP recovered completely and no recurrence occurred during 5 months of follow-up |
4 [9] | female | 53 | Adamuzumab (40 mg biweekly) was treated for 10 months | Four IVIG treatments (400 mg/kg/d for 5 days); Oral prednisolone (1 mg/kg, reduced at a rate of 10 mg every 2 weeks) | CIDP recovered completely and no recurrence occurred during 12 months of follow-up |